Aprepitant 80 MG capsule UD 6S
Ended Awarded
- Contract number
- SPE2DR26F61K1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,701
Award facts
- Contract value 100% obligated
- $10,700.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Aprepitant 80 mg capsule unit dose packages in quantities of six, with a contract ceiling value of $10,700.65. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the order is scheduled for completion by November 18, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that supports global pharmaceutical supply to military healthcare programs.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor for federal medical procurement, with an extensive portfolio of contract awards supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As the prime contractor under this agreement, the company provides a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Aprepitant delivery represents a critical antiemetic medication used primarily in chemotherapy-related nausea and vomiting treatment protocols, consistent with AmerisourceBergen's role as a key supplier of specialty medications to federal military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F61K1?
SPE2DR26F61K1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F61K1 worth?
The government has obligated $10,701 on SPE2DR26F61K1.
Is contract SPE2DR26F61K1 an order under another contract?
Yes. SPE2DR26F61K1 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F61K1 competed?
The extent of competition for SPE2DR26F61K1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award